MDT Stock Recent News
MDT LATEST HEADLINES
Medtronic is the world's largest medical device company, and it has a 46-year streak of consecutive annual dividend raises. Cigarette sales are steadily declining, but Altria Group's bottom line keeps on climbing.
Dividend stocks are an excellent source of passive income. Some dividend payers are markedly safer investments than their peers, however.
Medtronic (MDT) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.30 per share a year ago.
Investing in dividend stocks is generally reserved for those who prefer steady returns and low volatility over the thrill of rapid potential gains. Investors saw tech stocks explode in 2023 as artificial intelligence emerged.
Today's dividend stocks are increasingly popular in a wild reversal as top tech stocks take center stage and push market indices back to all-time highs. But that presents a prime opportunity for income investors and long-term “buy and hold” strategists.
The latest trading day saw Medtronic (MDT) settling at $86.97, representing a -0.54% change from its previous close.
Medtronic's global medical device business has supported annual dividend raises since 1978, and it's well positioned for more growth. AbbVie's lead drug fell off a patent cliff last year, but soaring sales of recently launched treatments make the stock a buy right now.
2024 could easily turn into the year that value stocks come out on top. Though “official” numbers say differently, there's a clear sense of unease as tech-heavy indices soar to all-time highs despite wide-ranging layoffs pointing to troubled economic conditions.
We outline an Income Strategy for creating a self-sufficient portfolio for retirees and income-focused investors with $1 million to generate a life-long income stream. We explain the benefits of generating income through dividends and distributions rather than selling shares for capital gains. We compare the results of backtesting an income strategy with index investing for the past 24 years, starting from the year 2000.
After underperforming the broad market over the past year, shares of Medtronic offer a 3.4% dividend yield. AbbVie shares offer a juicy 3.8% dividend yield even though the payout has grown 287% over the past 10 years.